HDAC2 and chronic obstructive pulmonary disease: The underlying molecular mechanisms suggest that this happens through theophylline increasing the activity of the nuclear enzyme histone deacetylase-2 (HDAC2), which is decreased in COPD, therefore preventing the anti-inflammatory effect of corticosteroids [1].